Indaptus Therapeutics
Price & Volume
Stats
See more52W Range | $0.92-$5.96 |
Market Cap | $512.9M |
Shares Short | 916,352 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.56 |
News
See moreYahoo Finance • 3 months ago
Top Biotech Gainers: QURE Rallies On AMT-130 Update, LNAI On Track, FTH Eyes Q4 Data, ELTX On Watch
Yahoo Finance • 3 months ago
Abbott Cooper PLLC Announces Investigation on Behalf of Indaptus Therapeutics, Inc. Stockholders
Yahoo Finance • 9 months ago
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar
About
CEO | Mr. Junyi Dai |
Address | Three Columbus Circle, New York, NY, United States, 10019 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 5 |